Fri, May 8, 2020

Alethia Young Reiterated (ARWR) at Buy with Decreased Target to $58 on, May 8th, 2020

Alethia Young of Cantor Fitzgerald, Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy with Decreased Target from $60 to $58 on, May 8th, 2020.

Alethia has made no other calls on ARWR in the last 4 months.



There are 3 other peers that have a rating on ARWR. Out of the 3 peers that are also analyzing ARWR, 2 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Upgraded from Sell to Hold on, Tuesday, March 24th, 2020
  • Salveen Richter of "Goldman Sachs" Initiated at Hold and Held Target at $45 on, Tuesday, March 17th, 2020


This is the rating of the analyst that currently disagrees with Alethia


  • Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $57 on, Friday, March 13th, 2020